Literature DB >> 16958617

Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area.

Mark L Bannister1, Tomoyo Hamada, Takashi Murayama, Peta J Harvey, Marco G Casarotto, Angela F Dulhunty, Noriaki Ikemoto.   

Abstract

To explain the mechanism of pathogenesis of channel disorder in MH (malignant hyperthermia), we have proposed a model in which tight interactions between the N-terminal and central domains of RyR1 (ryanodine receptor 1) stabilize the closed state of the channel, but mutation in these domains weakens the interdomain interaction and destabilizes the channel. DP4 (domain peptide 4), a peptide corresponding to residues Leu2442-Pro2477 of the central domain, also weakens the domain interaction and produces MH-like channel destabilization, whereas an MH mutation (R2458C) in DP4 abolishes these effects. Thus DP4 and its mutants serve as excellent tools for structure-function studies. Other MH mutations have been reported in the literature involving three other amino acid residues in the DP4 region (Arg2452, Ile2453 and Arg2454). In the present paper we investigated the activity of several mutants of DP4 at these three residues. The ability to activate ryanodine binding or to effect Ca2+ release was severely diminished for each of the MH mutants. Other substitutions were less effective. Structural studies, using NMR analysis, revealed that the peptide has two a-helical regions. It is apparent that the MH mutations are clustered at the C-terminal end of the first helix. The data in the present paper indicates that mutation of residues in this region disrupts the interdomain interactions that stabilize the closed state of the channel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16958617      PMCID: PMC1698659          DOI: 10.1042/BJ20060902

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Trends Cardiovasc Med       Date:  2002-07       Impact factor: 6.677

2.  Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor.

Authors:  Takeshi Yamamoto; Noriaki Ikemoto
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

3.  Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.

Authors:  B M Manning; K A Quane; P J Lynch; A Urwyler; V Tegazzin; R Krivosic-Horber; K Censier; G Comi; P Adnet; W Wolz; J Lunardi; C R Muller; T V McCarthy
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Measurement of calcium release in isolated membrane systems: coupling between the transverse tubule and sarcoplasmic reticulum.

Authors:  N Ikemoto; D H Kim; B Antoniu
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

6.  Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.

Authors:  V Barone; O Massa; E Intravaia; A Bracco; A Di Martino; V Tegazzin; S Cozzolino; V Sorrentino
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

7.  Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.

Authors:  J Tong; H Oyamada; N Demaurex; S Grinstein; T V McCarthy; D H MacLennan
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

8.  A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation.

Authors:  Henrik Rueffert; Derk Olthoff; Christine Deutrich; Ralf Schober; Ursula G Froster
Journal:  Am J Med Genet A       Date:  2004-01-30       Impact factor: 2.802

9.  Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor.

Authors:  Shigeki Kobayashi; Takeshi Yamamoto; Jerome Parness; Noriaki Ikemoto
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 10.  Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects.

Authors:  J R Mickelson; C F Louis
Journal:  Physiol Rev       Date:  1996-04       Impact factor: 37.312

View more
  8 in total

1.  Effects of conformational peptide probe DP4 on bidirectional signaling between DHPR and RyR1 calcium channels in voltage-clamped skeletal muscle fibers.

Authors:  Rotimi O Olojo; Erick O Hernández-Ochoa; Noriaki Ikemoto; Martin F Schneider
Journal:  Biophys J       Date:  2011-05-18       Impact factor: 4.033

2.  Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.

Authors:  Takashi Murayama; Toshiharu Oba; Hiroshi Hara; Kikuo Wakebe; Noriaki Ikemoto; Yasuo Ogawa
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

3.  Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.

Authors:  Takashi Kimura; John D Lueck; Peta J Harvey; Suzy M Pace; Noriaki Ikemoto; Marco G Casarotto; Robert T Dirksen; Angela F Dulhunty
Journal:  Cell Calcium       Date:  2009-01-07       Impact factor: 6.817

Review 4.  Structures of the colossal RyR1 calcium release channel.

Authors:  Oliver B Clarke; Wayne A Hendrickson
Journal:  Curr Opin Struct Biol       Date:  2016-09-27       Impact factor: 6.809

Review 5.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

Review 6.  Review of RyR1 pathway and associated pathomechanisms.

Authors:  Jessica W Witherspoon; Katherine G Meilleur
Journal:  Acta Neuropathol Commun       Date:  2016-11-17       Impact factor: 7.801

7.  Correlation of phenotype with genotype and protein structure in RYR1-related disorders.

Authors:  Joshua J Todd; Vatsala Sagar; Tokunbor A Lawal; Carolyn Allen; Muslima S Razaqyar; Monique S Shelton; Irene C Chrismer; Xuemin Zhang; Mary M Cosgrove; Anna Kuo; Ruhi Vasavada; Minal S Jain; Melissa Waite; Dinusha Rajapakse; Jessica W Witherspoon; Graeme Wistow; Katherine G Meilleur
Journal:  J Neurol       Date:  2018-08-28       Impact factor: 4.849

Review 8.  Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.

Authors:  Angela F Dulhunty; Nicole A Beard; Marco G Casarotto
Journal:  F1000Res       Date:  2018-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.